Cell-free DNA methylome and fragmentome analysis for disease relapse monitoring in patients with Ewing Sarcoma
Richardson, S. A.; Gulati, G.; Harker, P. J. B.; Redfern, A.; Pearce, S. P.; Karimpour, M.; Hill, S. M.; Makeev, V. J.; Brennan, B.; Lee, A. T.; Clipson, A.; Dive, C.; Rothwell, D. G.; McCabe, M. G.; Mouliere, F.
Show abstract
Liquid biopsies and cell-free DNA (cfDNA) offer minimally invasive methods for the diagnosis and monitoring of Ewing Sarcoma (EwS). EwS have a low tumour mutational burden and their detection with plasma cfDNA is challenging. We hypothesised that analysing the cfDNA methylome and fragmentome could enhance sensitivity for detecting EwS and identifying early disease recurrence. We conducted whole-genome and methylome sequencing of cfDNA from 68 serial samples of 15 patients with EwS and 3 patients with CIC-rearranged sarcoma (CIC). With EwingSign, a new machine learning model, we identified EwS or CIC in a test set for 10 out of 12 patients at diagnosis and 15 out of 18 clinically confirmed relapse events. 0 out of 29 non-cancer controls were detected positive with EwingSign. These findings indicate that cfDNA methylome and fragmentome analysis, if validated in a larger cohort, could improve disease detection, monitoring and relapse identification in patients with EwS.
Matching journals
The top 4 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Partner-independent fusion gene detection by multiplexed CRISPR/Cas9 enrichment and long-read Nanopore sequencing 96%
- Integrative ensemble modelling of cetuximab sensitivity in colorectal cancer PDXs 96%
- Spatial transcriptomics reveals ovarian cancer subclones with distinct tumour microenvironments 95%
Similar papers in this journal
- Non-invasive multi-cancer detection using DNA hypomethylation of LINE-1 retrotransposons 95%
- Cell-free urine- and plasma DNA mutational analysis predicts neoadjuvant chemotherapy response and outcome in patients with muscle invasive bladder cancer 94%
- cfTrack : Exome-wide mutation analysis of cell-free DNA to simultaneously monitor the full spectrum of cancer treatment outcomes: MRD, recurrence, and evolution 93%
Similar papers in this journal
- Multimodal Spatial Proteomic Profiling in Acute Myeloid Leukemia 94%
- Predicting the Tumor Microenvironment Composition and Immunotherapy Response in Non-Small Cell Lung Cancer from Digital Histopathology Images 94%
- Explainable, federated deep learning model predicts disease progression risk of cutaneous squamous cell carcinoma 94%
Similar papers in this journal
- Patient-derived xenografts and single-cell sequencing identifies three subtypes of tumor-reactive lymphocytes in uveal melanoma metastases 95%
- Unveiling the influence of tumor and immune signatures on immune checkpoint therapy in advanced lung cancer 94%
- Detection of malignant peripheral nerve sheath tumors in patients with neurofibromatosis using aneuploidy and mutation identification in plasma 94%
Similar papers in this journal
- Short and long-read genome sequencing methodologies for somatic variant detection; genomic analysis of a patient with diffuse large B-cell lymphoma 95%
- Molecular counting enables accurate and precise quantification of methylated ctDNA for tumor-naive cancer therapy response monitoring 95%
- Integrated genomics identify novel immunotherapy targets for malignant mesothelioma 95%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.